MetaCap

EDAP TMS S.A. Insider Trades

NASDAQ: FOCLHealth CareBiotechnology: Electromedical & Electrotherapeutic ApparatusUSD

4.19+0.065 (+1.58%)

At close: Oct 9, 4:00 PM ET · Delayed 15 min

Last 12 months

Purchases
9 · $593.20K
Sales
0 · $0
Shares bought / sold
126.00K / 0
Net activity
Net buying $593,200

EDAP TMS S.A. insider activity

Over the last 12 months, EDAP TMS S.A. insiders reported 13 transactions on SEC Form 4: 9 open-market purchases and 0 sales. Insiders bought $593,200 and sold $0 worth of stock, for net insider buying of $593,200. The most recent filing shows Schulz Fran (Director) buying 10,000 shares at $4.75 on Aug 14, 2026.

Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put FOCL's ownership changes in context.

Summary generated from market data by MetaCap's automated system. Methodology

FOCL insider transactions

EDAP TMS S.A. insider transactions
DateInsiderTypeSharesValueFiling
Aug 14, 2026Annen StevenSVP, Marketing & Product Mgmt.Buy5,000$23.75KForm 4
Aug 14, 2026Rhodes RyanChief Executive OfficerBuy21,000$99.75KForm 4
Aug 14, 2026Mobeck Kenneth S.Chief Financial OfficerBuy5,000$23.75KForm 4
Aug 14, 2026Shah SanketGeneral Counsel & Corp SecBuy5,000$23.75KForm 4
Aug 14, 2026WILLSEY LANCEDirectorBuy50,000$237.50KForm 4
Aug 14, 2026LEVINE JOSHUADirectorBuy10,000$47.50KForm 4
Aug 14, 2026Horn David R.DirectorBuy10,000$47.50KForm 4
Aug 14, 2026Schulz FranDirectorBuy10,000$47.50KForm 4
May 12, 2026Annen StevenSVP, Marketing & Product Mgmt.Award90,000—Form 4
May 12, 2026Mobeck Kenneth S.Chief Financial OfficerAward120,000—Form 4
May 12, 2026Rhodes RyanChief Executive OfficerAward304,500—Form 4
May 12, 2026Shah SanketGen Counsel & Corp SecretaryAward67,500—Form 4
May 11, 2026LEVINE JOSHUADirectorBuy10,000$42.20KForm 4

Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4

Related